Laszlo B. Tanko MD, PhD, DMSc, eMBA
Laszlo B. Tanko MD, PhD, DMSc, eMBA
Bayer Pharmaceuticals
Потвърден имейл адрес: bayer.com
Relationship between osteoporosis and cardiovascular disease in postmenopausal women
LB Tankó, C Christiansen, DA Cox, MJ Geiger, MA McNabb, ...
Journal of Bone and Mineral Research 20 (11), 1912-1920, 2005
Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women
LB Tanko, YZ Bagger, P Alexandersen, PJ Larsen, C Christiansen
Circulation 107 (12), 1626-1631, 2003
Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women
LB Tanko, YZ Bagger, C Christiansen
Calcified tissue international 73, 15-20, 2003
Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application
P Høegh-Andersen, LB Tankó, TL Andersen, CV Lundberg, JA Mo, ...
Arthritis Res Ther 6, 1-12, 2004
Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women
LB Tanko, YZ Bagger, G Qin, P Alexandersen, PJ Larsen, C Christiansen
Circulation 111 (15), 1883-1890, 2005
Radiographic measure of aorta calcification is a site‐specific predictor of bone loss and fracture risk at the hip
YZ Bagger, LB Tanko, P Alexandersen, G Qin, C Christiansen, ...
Journal of internal medicine 259 (6), 598-605, 2006
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study
YZ Bagger, LB Tankó, P Alexandersen, HB Hansen, A Møllgaard, P Ravn, ...
Bone 34 (4), 728-735, 2004
An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners
LB Tankó, C Christiansen
Menopause 11 (1), 104-109, 2004
Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?
YZ Bagger, HB Rasmussen, P Alexandersen, T Werge, C Christiansen, ...
Osteoporosis international 18, 505-512, 2007
Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and …
U Mouritzen, S Christgau, HJ Lehmann, LB Tanko, C Christiansen
Annals of the Rheumatic Diseases 62 (4), 332-336, 2003
Early postmenopausal hormone therapy may prevent cognitive impairment later in life
YZ Bagger, LB Tankó, P Alexandersen, G Qin, C Christiansen, ...
Menopause 12 (1), 12-17, 2005
An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice
DJ Leeming, P Alexandersen, MA Karsdal, P Qvist, S Schaller, LB Tanko
European journal of clinical pharmacology 62, 781-792, 2006
Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation
S Oestergaard, BC Sondergaard, P Hoegh‐Andersen, K Henriksen, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2006
Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM)
S Christgau, LB Tankó, PAC Cloos, U Mouritzen, C Christiansen, ...
Menopause 11 (5), 508-518, 2004
Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?
LB Tanko, YZ Bagger, SB Nielsen, C Christiansen
Bone 32 (1), 8-14, 2003
Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases
K Henriksen, LB Tanko, P Qvist, PD Delmas, C Christiansen, MA Karsdal
Osteoporosis international 18, 681-685, 2007
The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients
DJ Leeming, M Koizumi, I Byrjalsen, B Li, P Qvist, LB Tankó
Cancer Epidemiology Biomarkers & Prevention 15 (1), 32-38, 2006
Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis
LB Tankó, JM Bruun, P Alexandersen, YZ Bagger, B Richelsen, ...
Circulation 110 (15), 2246-2252, 2004
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal
YZ Bagger, LB Tankó, P Alexandersen, P Ravn, C Christiansen
Bone 33 (3), 301-307, 2003
In Vitro, Ex Vivo, and In Vivo Methodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers …
S Schaller, K Henriksen, P Hoegh-Andersen, BC Søndergaard, EU Sumer, ...
Assay and drug development technologies 3 (5), 553-580, 2005
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20